We evaluated the efficiency of adenovirus-mediated gene targeted cells. A novel protocol for the efficient transduction transfer into normal and malignant human hematopoietic of adenovirus into B-CLL cells was presented. We showed cells. An E-1 and E-3 deleted, replication-defective recomthat anti-CD40 mAb or CD40 ligand acts in synergy with binant Ad.RSV␤gal vector was used and the transduction rhIL-4 to enable the transduction of approximately 50-75% efficiency was studied at a multiplicity of infection of 13 of B-CLL cells (B-CLL, n = 6). Expression of ␤-galactop.f.u. per cell. Approximately 40-50% of normal monocytes sidase in transduced CML cells and B-CLL cells was were transduced, whereas purified normal resting T cells detected for at least 15 days after transduction. The and B cells were resistant to infection. We showed that 50-present studies underline the utility of adenovirus vectors 80% of primary chronic myeloid leukemia cells (CML, n = for the construction of cytokine gene-modified tumor vac-12) were efficiently transduced. In contrast to CML, succines for the treatment of hematopoietic malignancies such cessful transduction of resting primary chronic B lymphoas CML and B-CLL. cytic leukemia cells required appropriate preactivation of ). The fusion gene (bcr/abl) encodes a tyrosine kinase were used to study the adenovirus-mediated gene transduction. Cells were incubated with Ad.RSV␤gal vector for 48 h and X-gal assay was performed on day 3. We found that less than 10% of unfractionated PBMCs for 3 days with rhGM-CSF (100 U/ml) before infection. Activation of cells with GM-CSF did not influence the (CD14 + , 90-98%) were readily transduced and stained transduction rate (data not shown). strongly positive for ␤-galactosidase (five separate experiments). Unlike the experience with retrovirus, we rhIL-4 together with hCD40 ligand are efficient and showed that efficient transduction of normal peripheral necessary for the transduction of primary B-CLL cells blood monocytes can be achieved with adenovirus withMononuclear cells from chronic B lymphocytic leukemia out preactivation of target cells. In contrast, purified (B-CLL, n = 6) patients were studied for adenoviral vector resting T lymphocytes (CD3 + , Ͼ96%) and B lymphocytes transduction. B-CLL cells were Ig-light chain restricted (CD19 + , Ͼ95%) were, however, not permissive to transand displayed CD5 (100%) and CD19 (80-95%) on the duction (three separate experiments).
Introduction
immunogenic. 9, 10 In B-CLL, tumor cells express clonal The concept of immunomodulatory gene therapy of idiotypic surface immunoglobulin (id-Ig) which repcancer is based on the presumption that the host immune resents a true tumor-specific antigen. Immune responses system is capable of recognizing tumor specific/ to id-Ig have been demonstrated in murine and human associated antigens, whereas the generation of an effec-B cell tumors. [11] [12] [13] [14] One approach for the treatment of tive antitumor immune response is inefficient. Transfer CML and B-CLL would thus be to use irradiated and of genes encoding for cytokines or adhesion molecules cytokine/adhesion molecule gene transduced tumor cells into syngeneic/autologous tumor cells may therefore as vaccines to augment the in vivo host immune response enhance the presentation of tumor antigens to the to cancer cells. immune system. [1] [2] [3] Studies in animal models have demIn the present studies, a replication-defective recombionstrated both protective and therapeutic efficiency of nant adenovirus vector, Ad.RSV␤gal was used for transgene-modified cellular vaccines in tumors such as meladuction of the reporter gene lacZ into normal or malignoma, 4 mastocytoma, 5 renal cell carcinoma 6 and sarnant hematopoietic cells including CML and B-CLL. This coma. 7 Transduc-tion of the GM-CSF gene into murine vector transduced resting normal monocytes and CML tumors appeared to be a most effective approach to gencells with high efficiency. Efficient transduction of B-CLL erate protective immunity. (Table 1) . No significant differences in cells preactivated with the combination of anti-CD40 transduction rates were observed using either freshly mAb or CD40 ligand plus rhIL-4 were efficiently transseparated CML cells or cells stored in liquid nitrogen. In duced ( Figure 4 ). This activation protocol was highly several repeated experiments, 50-80% of CML cells were effective in all primary B-CLL cells studied ( Figure 5 ). readily transduced with Ad.RSV␤gal (Figures 2 and 3) .
Similar results were observed using highly purified No cellular toxicity was observed during the incubation (99.7%) B-CLL cells (data not shown). On the other hand, of cells with viral vector. It was of interest to study neither IL-4 nor anti-CD40 mAb (or CD40 ligand) alone whether activation of CML cells with cytokines can was sufficient to enhance the transduction rate (less than improve the transduction rate. Cells were preactivated 5% of cells were transduced). The present studies were undertaken with the ultimate background; +, 5-10 × background; ++, 10-50 × background.
CML cells and B-CLL cells express recombinant lacZ
aim of constructing cytokine/adhesion molecule gene-
Figure 3 Expression of ␤-galactosidase in CML cells. (a) Untransduced CML cells; (b-f) transduced CML cells (× 20).
modified tumor vaccines for specific immunotherapy of was required, and no apparent cytotoxicity could be detected during short-term culture of CML cells with CML and B-CLL. Since these circulating tumor cells are largely restricted to the G0 stage of the cell cycle, the use virus. It is known that CML cells contain heterogeneous populations of different leukocyte lineages (although of retrovirus vectors is suboptimal since it requires preactivation and cycling of the tumor cells. 1 We therefore they are Ph + ). We performed several studies on the adhesion molecule expression of CML cells and B-CLL used a safety modified adenovirus vector (Ad.RSV␤-gal) carrying the lacZ reporter gene to transduce a range of cells before and after activation. We cannot provide a clear explanation at present for the differences in transfreshly isolated normal and malignant hematopoietic cells. In the present studies, we used low-titer virus duction efficiency of CML cells. Adenoviral receptor expression on CML cells and B-CLL cells needs to be (1.3 × 10 8 p.f.u./ml) for transduction. No significant increase in transduction rate was found using a 10-fold scrutinized further. When using a high-titer viral stock (10 10 -10 11 p.f.u./ml) higher titer of virus. We showed that adenovirus efficiently infects normal peripheral blood monocytes for the infection, the viability of transduced cells decreased dramatically.
In our studies, we tested differwithout preactivation of target cells, whereas normal resting T and B lymphocytes were resistant. It is therefore ent titers of the viral stock in order to improve the transduction rate and cell survival rate. We found that at 10 8 -evident that adenovirus infects preferentially the myelomonocytic cell lineage. 10 9 p.f.u./ml (13 p.f.u. per cell), a good transduction result can be achieved. A novel observation in this study was that 50-80% of unselected primary CML cells were readily transduced Using the present vector, investigators have often shown that adenovirus-mediated gene expression lasts with the adenovirus vector. No preactivation of the cells for several weeks to months.
19, 20 We showed that the long-term expression of ␤-galactosidase in transduced CML cells and B-CLL cells was detected for at least 15 days. In the tumor vaccine approach, triggering and subsequent boosting of a T cell response are readily achieved within 2 weeks. 21 Furthermore, lacZ gene expression by Ad.RSV␤gal transduced K562 cells persisted for at least 4 weeks of culture (data not shown).
Efficient transduction of B-CLL cells requires appropriate preactivation. We present here a novel protocol for the efficient transduction of adenovirus into B-CLL cells. We showed that anti-CD40 mAb or CD40 ligand acts in synergy with rhIL-4 to enable transduction of 50-75% of B-CLL cells.
Coculture with CD40L/anti-CD40 mAb plus IL-4 was earlier shown to stimulate B-CLL cells to enter the cell cycle. 22 In a cell proliferation study, we found that rIL-4 dine incorporation (data not shown). At present, it is unclear why B-CLL cells need to be preactivated in order to become susceptible to transduction. We suggested that since adenovirus-mediated transduction is receptor-dependent, activation of B-CLL cells likely leads to up-regulation of adenovirus receptors on cell surface.
Adenovirus was earlier shown to infect a broad host range, such as epithelial cells, myoblasts, keratinocytes and tumor cell lines. 1 Recent studies have highlighted some of the mechanisms which govern the uptake of adenovirus. Studies on adenovirus type 2 have shown that the cell surface integrin ␣ v ␤ 3 /␣ v ␤ 5 subunits are required for virus internalization. 23, 24 Recently, Acsadi et al 25 showed that cultured myoblasts expressed increased levels of ␤ 3 /␤ 5 integrins which directly correlated with their susceptibility to adenovirus infection.
Based on the observation that B-CLL cells, when activated with IL-4 plus anti-CD40 mAb/CD40L, show surface before or after the activation. The level of mAb staining on the cell populations was indicated by fluorescence intensity: −, no detectable staining; +/−, Ͻ5 × background; +, 5-10 × background; ++, 10-50 × background; +++, 50-100 × background.
Flow cytometric analysis showed that the combination
Materials and methods
of rhIL-4 plus anti-hCD40 mAb-induced phenotypic changes on B-CLL cell surface, predominately enhanced Enrichment of normal peripheral blood monocytes, expression of ICAM-1 (CD54). However, the expression T cells and B cells of integrins, such as ␣ v , ␤ 1 , ␤ 2 , ␤ 3 and ␤ 5 was unaltered Peripheral blood mononuclear cells (PBMCs) from heal-( Table 2) . Primary CML cells and normal peripheral thy blood donors were isolated from buffy coats by Ficblood monocytes expressed a low level of ␣ v integrin oll-Paque density gradient centrifugation. T cells were (CD51 , Tables 1 and 3 ). Expression of ␣ v ␤ 3 or ␣ v ␤ 5 inteenriched by rosetting with sheep erythrocytes treated grin was low on the surface of CML cells and we have with 2-aminoethyl isothiouronium bromide (AET; Sigma, not been able to block the adenovirus infection via RGD St Louis, MO, USA). The purity of T cells (CD3 + ) was peptides (data not shown).
greater than 96%. Non-T cells were further fractionated Taken together, our results show that a safety modified on a 53% Percoll gradient by centrifugation at 30 000 g adenovirus vector efficiently transduces primary CML for 20 min, at 20°C. 26, 27 Leukocytes from the upper band cells and B-CLL cells. Preactivation of the malignant B contained 60-80% monocytes (from four experiments). cells with IL-4 and anti-CD40 mAb/CD40L is necessary Monocytes were further enriched by adherence to plastic and sufficient for adenovirus-mediated gene transducPetri dishes. The purity of monocytes (CD14 + ) was 90-tion. Future and ongoing studies are focused on the con-98% as determined by flow cytometry. B cells were puristruction of the cytokine gene modified-tumor vaccines fied from the lower band. The resultant B cell population (GM-CSF, IL-12, INF␥ and B7) for therapeutic trials in was Ͼ95% (CD19 + ) pure. CML, B-CLL and other B cell malignancies.
Primary leukemia cells
Twelve untreated CML patients who exhibited 100% Philadelphia chromosome-positive metaphases were 28 tumor necrosis factor alpha (TNF␣, Sigma), med by cesium chloride density centrifugation. Titers of 100 ng/ml; forskolin, 1 ng/ml (Calbiochem, La Jolla, CA, the viral stocks were determined by plaque assay on 293 USA); anti-CD40 mAb (G28-5), 1 g/ml (a kind gift from cells (low passage; Microbix, Ontario, Canada) as described previously. 200 cells counted.
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